SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-11-064749
Filing Date
2011-03-14
Accepted
2011-03-14 06:14:40
Documents
44
Period of Report
2011-03-11
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d8k.htm 8-K 24459
2 PRESS RELEASE dex991.htm EX-99.1 25544
3 CELL THERAPEUTICS, INC. PRESENTATION SLIDES (FOR INVESTORS AND ANALYSTS) dex992.htm EX-99.2 146683
4 CELL THERAPEUTICS, INC. PRESENTATION SLIDES (FOR MEDIA) dex993.htm EX-99.3 37383
5 GRAPHIC g161846ex99_2s10gbgd.jpg GRAPHIC 55874
6 GRAPHIC g161846ex99_2s11gbgd.jpg GRAPHIC 23584
7 GRAPHIC g161846ex99_2s12gbgd.jpg GRAPHIC 45325
8 GRAPHIC g161846ex99_2s13gbgd.jpg GRAPHIC 36426
9 GRAPHIC g161846ex99_2s14gbgd.jpg GRAPHIC 36211
10 GRAPHIC g161846ex99_2s15gbgd.jpg GRAPHIC 31140
11 GRAPHIC g161846ex99_2s16gbgd.jpg GRAPHIC 44658
12 GRAPHIC g161846ex99_2s17gbgd.jpg GRAPHIC 34578
13 GRAPHIC g161846ex99_2s18gbgd.jpg GRAPHIC 47775
14 GRAPHIC g161846ex99_2s19gbgd.jpg GRAPHIC 23077
15 GRAPHIC g161846ex99_2s1gbgd.jpg GRAPHIC 67105
16 GRAPHIC g161846ex99_2s20gbgd.jpg GRAPHIC 21923
17 GRAPHIC g161846ex99_2s21gbgd.jpg GRAPHIC 57652
18 GRAPHIC g161846ex99_2s22gbgd.jpg GRAPHIC 43828
19 GRAPHIC g161846ex99_2s23gbgd.jpg GRAPHIC 23493
20 GRAPHIC g161846ex99_2s24gbgd.jpg GRAPHIC 21923
21 GRAPHIC g161846ex99_2s25gbgd.jpg GRAPHIC 25080
22 GRAPHIC g161846ex99_2s26gbgd.jpg GRAPHIC 23035
23 GRAPHIC g161846ex99_2s27gbgd.jpg GRAPHIC 23638
24 GRAPHIC g161846ex99_2s28gbgd.jpg GRAPHIC 23913
25 GRAPHIC g161846ex99_2s29gbgd.jpg GRAPHIC 22736
26 GRAPHIC g161846ex99_2s2gbgd.jpg GRAPHIC 21923
27 GRAPHIC g161846ex99_2s30gbgd.jpg GRAPHIC 22717
28 GRAPHIC g161846ex99_2s31gbgd.jpg GRAPHIC 39475
29 GRAPHIC g161846ex99_2s32gbgd.jpg GRAPHIC 23509
30 GRAPHIC g161846ex99_2s3gbgd.jpg GRAPHIC 24315
31 GRAPHIC g161846ex99_2s4gbgd.jpg GRAPHIC 23441
32 GRAPHIC g161846ex99_2s5gbgd.jpg GRAPHIC 50267
33 GRAPHIC g161846ex99_2s6gbgd.jpg GRAPHIC 25683
34 GRAPHIC g161846ex99_2s7gbgd.jpg GRAPHIC 21923
35 GRAPHIC g161846ex99_2s8gbgd.jpg GRAPHIC 23819
36 GRAPHIC g161846ex99_2s9gbgd.jpg GRAPHIC 23151
37 GRAPHIC g161846ex99_3s1gbgd.jpg GRAPHIC 67105
38 GRAPHIC g161846ex99_3s2gbgd.jpg GRAPHIC 21792
39 GRAPHIC g161846ex99_3s3gbgd.jpg GRAPHIC 24184
40 GRAPHIC g161846ex99_3s4gbgd.jpg GRAPHIC 23489
41 GRAPHIC g161846ex99_3s5gbgd.jpg GRAPHIC 23381
42 GRAPHIC g161846ex99_3s6gbgd.jpg GRAPHIC 40582
43 GRAPHIC g161846ex99_3s7gbgd.jpg GRAPHIC 23736
44 GRAPHIC g161846g47x80.jpg GRAPHIC 6911
  Complete submission text file 0001193125-11-064749.txt   1983791
Mailing Address 501 ELLIOTT AVE W STE 400 SEATTLE WA 98119
Business Address 501 ELLIOTT AVE W STE 400 SEATTLE WA 98119 2062827100
CELL THERAPEUTICS INC (Filer) CIK: 0000891293 (see all company filings)

IRS No.: 911533912 | State of Incorp.: WA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-12465 | Film No.: 11683815
SIC: 2834 Pharmaceutical Preparations